Exercise is a key component in the prevention and treatment of many obesity-related metabolic complications, including insulin resistance and type 2 diabetes. High intensity interval training (HIIT), which alternates brief high-intensity efforts ith brief recovery periods, has been found to markedly improve clinical markers of metabolic health (meal tolerance, 24h glucose). Therefore, HIIT may be considered an effective and time- efficient alternative to conventional exercise. Importantly, HIIT has also been found to be safe and well tolerated in obese and type 2 diabetic patients. The exercise stimulus of HIIT is obviously very different from conventional exercise, and can yield unique adaptions. However, mechanisms underlying HIIT-induced improvements in metabolic health remain poorly understood. In addition, variations in the main components of HIIT (# of intervals, exercise time, energy expended) may induce very different metabolic outcomes, yet a systematic assessment of deviations in these parameters has not been conducted. Furthermore, while available evidence clearly demonstrates HIIT can induce impressive health benefits after a few to several weeks of training, the ability/willingness of obese adults to adhere to a long-term HIIT program is not known. Our overall objectives are to: 1) comprehensively assess putative mechanisms underlying HIIT-induced improvements in insulin resistance at the whole-body, tissue, and cellular levels, 2) systematically evaluate the impact of different doses of HIIT that may be optimal for improving metabolic health in obese adults, and 3) assess the ability/willingness of obese subjects to adhere to long-term HIIT programs.
In Specific Aim #1, we will examine the effects of 3 months of HIIT (10 x 1min at ~90%maximal heart rate [HRmax]; 4d/wk) on changes in key clinical health outcomes (e.g., insulin resistance, 24h glucose control, hepatic lipid accumulation, blood lipid profile) in obese adults with impaired glucose tolerance. We will also compare HIIT with conventional exercise-training involving steady-state exercise for 45 min at 60-70%HRmax (which represents a common exercise prescription for health and fitness).
Specific Aim #2 will determine factors underlying the improvements in insulin resistance (e.g., reduced lipid accumulation in skeletal muscle, lower macrophage infiltration and markers of inflammation in adipose tissue and skeletal muscle, and/or enhanced insulin signaling).
Specific Aim #3 will address important clinical/applied issues regarding the optimization of HIIT by systematically evaluating the effects of the number of intervals, exercise time, and energy expended during HIIT on insulin resistance - and we will also assess the ability/willingness of obese adults with impaired glucose tolerance to adhere to HIIT programs for up to 1 year. Findings from these studies will greatly expand our understanding about the effects of HIIT on metabolic health, and will provide tremendously valuable information for the design of programs aimed at maximizing key metabolic benefits of exercise.
Exercise is a key component in the prevention and treatment of obesity-related metabolic complications, such as insulin resistance and type 2 diabetes. Recent evidence clearly demonstrates High intensity interval training (HIIT), which alternates brief high-intensity efforts with brief recovery periods, is a very effective and time-efficient alternative to 'conventional' exercise (i.e., moderate intensity continuous exercise). However, little is known about metabolic adaptations stemming from HIIT and less is known about optimizing HIIT regimens specifically for improvements in metabolic health. Moreover, while available evidence demonstrates HIIT can induce impressive health benefits after a few to several weeks of training, the ability/willingness of obese adults to adhere to HIIT programs over the long term is not known. Our overall goals are to: 1) comprehensively assess mechanisms underlying HIIT-induced improvements in insulin resistance at the whole-body, tissue, and cellular levels, 2) systematically evaluate the impact of different 'doses' of HIIT that may be optimal for improving metabolic health in obese adults, and 3) assess the ability/willingness of obese subjects to adhere to long-term HIIT programs.
|Van Pelt, Douglas W; Guth, Lisa M; Horowitz, Jeffrey F (2017) Aerobic exercise elevates markers of angiogenesis and macrophage IL-6 gene expression in the subcutaneous adipose tissue of overweight-to-obese adults. J Appl Physiol (1985) 123:1150-1159|
|Van Pelt, Douglas W; Guth, Lisa M; Wang, Abigail Y et al. (2017) Factors regulating subcutaneous adipose tissue storage, fibrosis, and inflammation may underlie low fatty acid mobilization in insulin-sensitive obese adults. Am J Physiol Endocrinol Metab 313:E429-E439|
|Van Pelt, D W; Newsom, S A; Schenk, S et al. (2015) Relatively low endogenous fatty acid mobilization and uptake helps preserve insulin sensitivity in obese women. Int J Obes (Lond) 39:149-55|
|Newsom, Sean A; Everett, Allison C; Park, Sanghee et al. (2015) Lipid mixtures containing a very high proportion of saturated fatty acids only modestly impair insulin signaling in cultured muscle cells. PLoS One 10:e0120871|
|Nelson, Rachael K; Horowitz, Jeffrey F (2014) Acute exercise ameliorates differences in insulin resistance between physically active and sedentary overweight adults. Appl Physiol Nutr Metab 39:811-8|
|Boon, James; Hoy, Andrew J; Stark, Romana et al. (2013) Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes 62:401-10|
|Nelson, Rachael K; Horowitz, Jeffrey F; Holleman, Robert G et al. (2013) Daily physical activity predicts degree of insulin resistance: a cross-sectional observational study using the 2003-2004 National Health and Nutrition Examination Survey. Int J Behav Nutr Phys Act 10:10|
|Newsom, Sean A; Everett, Allison C; Hinko, Alexander et al. (2013) A single session of low-intensity exercise is sufficient to enhance insulin sensitivity into the next day in obese adults. Diabetes Care 36:2516-22|
|Watt, M J; Barnett, A C; Bruce, C R et al. (2012) Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide. Diabetologia 55:2741-2746|
|Cornford, Andrea S; Barkan, Ariel L; Horowitz, Jeffrey F (2011) Rapid suppression of growth hormone concentration by overeating: potential mediation by hyperinsulinemia. J Clin Endocrinol Metab 96:824-30|